- Home
- GHI vs CRBU Comparison
GHI vs CRBU Comparison
Compare GHI & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHI
- CRBU
- Stock Information
- Founded
- GHI 1998
- CRBU 2011
- Country
- GHI United States
- CRBU United States
- Employees
- GHI N/A
- CRBU N/A
- Industry
- GHI Finance: Consumer Services
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- GHI Finance
- CRBU Health Care
- Exchange
- GHI Nasdaq
- CRBU Nasdaq
- Market Cap
- GHI 252.3M
- CRBU 236.3M
- IPO Year
- GHI N/A
- CRBU 2021
- Fundamental
- Price
- GHI $10.65
- CRBU $1.78
- Analyst Decision
- GHI Strong Buy
- CRBU Strong Buy
- Analyst Count
- GHI 4
- CRBU 4
- Target Price
- GHI $17.50
- CRBU $12.00
- AVG Volume (30 Days)
- GHI 108.2K
- CRBU 1.5M
- Earning Date
- GHI 11-06-2024
- CRBU 11-06-2024
- Dividend Yield
- GHI 13.75%
- CRBU N/A
- EPS Growth
- GHI N/A
- CRBU N/A
- EPS
- GHI 0.61
- CRBU N/A
- Revenue
- GHI $34,307,528.00
- CRBU $11,475,000.00
- Revenue This Year
- GHI N/A
- CRBU N/A
- Revenue Next Year
- GHI $10.35
- CRBU N/A
- P/E Ratio
- GHI $17.42
- CRBU N/A
- Revenue Growth
- GHI 28.98
- CRBU N/A
- 52 Week Low
- GHI $10.32
- CRBU $1.50
- 52 Week High
- GHI $17.48
- CRBU $8.33
- Technical
- Relative Strength Index (RSI)
- GHI 33.30
- CRBU 37.34
- Support Level
- GHI $10.32
- CRBU $1.82
- Resistance Level
- GHI $11.53
- CRBU $1.97
- Average True Range (ATR)
- GHI 0.37
- CRBU 0.15
- MACD
- GHI -0.03
- CRBU -0.03
- Stochastic Oscillator
- GHI 20.12
- CRBU 6.25
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.